Baptist Health Medical Group INC
Baptist Health Medical Group INC was paid $26.58M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoBAPTIST HEALTH MEDICAL GROUP INC
LOUISVILLE, KY 40299
LOUISVILLE, KY 40299
33aNPI1508269200assigned 10/08/2014
33bProvider typePhysical Therapist
28Total paid$26.58M
24GClaims886,993
24DCodes billed65
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Physical Therapist providers in Kentucky
Rank by total paid#1 of 148
Median peer was paid$61K
This provider vs. median435×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official CLAY, DANYEL controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 76,756 | $2.47M | |
| 2019 | 98,007 | $2.99M | |
| 2020 | 84,581 | $2.43M | |
| 2021 | 135,876 | $3.92M | |
| 2022 | 184,023 | $5.52M | |
| 2023 | 176,539 | $5.28M | |
| 2024incomplete | 131,211 | $3.97M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 300,024 | 276,557 | $9.76M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 83,121 | 77,818 | $4.15M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.0% | 42,521 | 38,480 | $2.38M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 6.3% | 69,021 | 58,581 | $1.68M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5.7% | 70,270 | 27,320 | $1.53M |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.9% | 95,292 | 89,845 | $1.30M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4.0% | 31,535 | 10,420 | $1.07M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.0% | 33,880 | 13,207 | $1.05M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.7% | 41,459 | 39,447 | $986K |
| 87428 | 3.2% | 29,091 | 27,540 | $844K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 1.9% | 28,891 | 12,038 | $503K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1.3% | 17,549 | 6,887 | $352K |
53 more codes
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 3,841 | $141K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,659 | $135K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,742 | $134K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,793 | $128K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,232 | $79K |
| 97162 | <1% | 1,159 | $48K | |
| 87807 | <1% | 3,430 | $41K | |
| 92609 | <1% | 625 | $35K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,228 | $31K |
| 99284 | Emergency room visit (serious) | <1% | 510 | $31K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 1,236 | $20K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,393 | $16K |
| 99283 | Emergency room visit (moderate) | <1% | 394 | $15K |
| 81025 | <1% | 2,143 | $13K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 109 | $13K |
| 97014 | <1% | 1,985 | $13K | |
| 97161 | <1% | 294 | $12K | |
| 97533 | <1% | 434 | $12K | |
| 97113 | <1% | 188 | $9K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 714 | $6K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 588 | $5K |
| 92523 | <1% | 44 | $4K | |
| 99422 | <1% | 262 | $4K | |
| 97116 | <1% | 233 | $3K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 348 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 354 | $3K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 20 | $2K |
| 99201 | <1% | 71 | $2K | |
| 97035 | <1% | 224 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 939 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 152 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 161 | $1K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 138 | $902.62 |
| 87400 | <1% | 84 | $735.14 | |
| 97166 | <1% | 13 | $712.30 | |
| 81003 | <1% | 1,294 | $672.94 | |
| 73630 | <1% | 73 | $573.22 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 234 | $539.97 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 176 | $392.70 |
| 73610 | <1% | 32 | $345.97 | |
| 97032 | <1% | 38 | $236.89 | |
| 99406 | <1% | 14 | $111.82 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 14 | $108.21 |
| 99421 | <1% | 16 | $105.76 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 12 | $70.38 |
| 86308 | <1% | 14 | $62.31 | |
| 90633 | <1% | 370 | $47.95 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 92 | $23.10 |
| 90734 | <1% | 75 | $18.40 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 42 | $12.68 |
| 90686 | 0% | 60 | $0.00 | |
| 90715 | 0% | 15 | $0.00 | |
| 99001 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCLAY, DANYEL (VICE PRESIDEDNT, REVENUE CYCLE)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.